Duncker Streett & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $86.5K | Hold |
552
| – | – | 0.01% | 290 |
|
|
2026
Q1 | $84.3K | Hold |
552
| – | – | 0.02% | 293 |
|
|
2025
Q4 | $76.1K | Hold |
552
| – | – | 0.01% | 290 |
|
|
2025
Q3 | $70.8K | Hold |
552
| – | – | 0.01% | 301 |
|
|
2025
Q2 | $66.8K | Hold |
552
| – | – | 0.01% | 303 |
|
|
2025
Q1 | $61.5K | Hold |
552
| – | – | 0.01% | 302 |
|
|
2024
Q4 | $53.7K | Sell |
552
-440
| -44% | -$46.9K | 0.01% | 319 |
|
|
2024
Q3 | $114K | Hold |
992
| – | – | 0.02% | 271 |
|
|
2024
Q2 | $106K | Sell |
992
-71
| -7% | -$7.13K | 0.02% | 272 |
|
|
2024
Q1 | $103K | Hold |
1,063
| – | – | 0.02% | 274 |
|
|
2023
Q4 | $107K | Hold |
1,063
| – | – | 0.02% | 263 |
|
|
2023
Q3 | $108K | Hold |
1,063
| – | – | 0.03% | 251 |
|
|
2023
Q2 | $107K | Hold |
1,063
| – | – | 0.02% | 248 |
|
|
2023
Q1 | $97.8K | Hold |
1,063
| – | – | 0.02% | 249 |
|
|
2022
Q4 | $96.4K | Hold |
1,063
| – | – | 0.02% | 253 |
|
|
2022
Q3 | $81K | Sell |
1,063
-170
| -14% | -$14.1K | 0.02% | 266 |
|
|
2022
Q2 | $104K | Hold |
1,233
| – | – | 0.02% | 255 |
|
|
2022
Q1 | $108K | Sell |
1,233
-200
| -14% | -$17.3K | 0.02% | 270 |
|
|
2021
Q4 | $125K | Sell |
1,433
-300
| -17% | -$24.9K | 0.02% | 273 |
|
|
2021
Q3 | $142K | Hold |
1,733
| – | – | 0.03% | 257 |
|
|
2021
Q2 | $158K | Sell |
1,733
-1,525
| -47% | -$136K | 0.03% | 248 |
|
|
2021
Q1 | $278K | Sell |
3,258
-1,530
| -32% | -$137K | 0.05% | 212 |
|
|
2020
Q4 | $452K | Sell |
4,788
-1,180
| -20% | -$103K | 0.09% | 177 |
|
|
2020
Q3 | $519K | Sell |
5,968
-230
| -4% | -$19.9K | 0.11% | 159 |
|
|
2020
Q2 | $541K | Hold |
6,198
| – | – | 0.13% | 153 |
|
|
2020
Q1 | $511K | Buy |
6,198
+135
| +2% | +$12K | 0.14% | 151 |
|
|
2019
Q4 | $574K | Sell |
6,063
-2,060
| -25% | -$185K | 0.12% | 166 |
|
|
2019
Q3 | $706K | Sell |
8,123
-537
| -6% | -$48.2K | 0.16% | 143 |
|
|
2019
Q2 | $791K | Sell |
8,660
-1,457
| -14% | -$123K | 0.18% | 135 |
|
|
2019
Q1 | $872K | Hold |
10,117
| – | – | 0.2% | 125 |
|
|
2018
Q4 | $778K | Sell |
10,117
-1,785
| -15% | -$139K | 0.21% | 120 |
|
|
2018
Q3 | $919K | Buy |
11,902
+558
| +5% | +$41.3K | 0.21% | 127 |
|
|
2018
Q2 | $768K | Hold |
11,344
| – | – | 0.19% | 135 |
|
|
2018
Q1 | $822K | Buy |
11,344
+1,004
| +10% | +$76.4K | 0.21% | 131 |
|
|
2017
Q4 | $778K | Hold |
10,340
| – | – | 0.2% | 133 |
|
|
2017
Q3 | $795K | Sell |
10,340
-335
| -3% | -$25.3K | 0.24% | 119 |
|
|
2017
Q2 | $798K | Buy |
10,675
+1,580
| +17% | +$112K | 0.25% | 115 |
|
|
2017
Q1 | $605K | Hold |
9,095
| – | – | 0.19% | 138 |
|
|
2016
Q4 | $594K | Buy |
9,095
+223
| +3% | +$14.5K | 0.2% | 134 |
|
|
2016
Q3 | $628K | Buy |
8,872
+41
| +0.5% | +$2.99K | 0.22% | 127 |
|
|
2016
Q2 | $653K | Sell |
8,831
-112
| -1% | -$7.74K | 0.23% | 115 |
|
|
2016
Q1 | $580K | Sell |
8,943
-334
| -4% | -$22.7K | 0.21% | 123 |
|
|
2015
Q4 | $715K | Hold |
9,277
| – | – | 0.27% | 105 |
|
|
2015
Q3 | $764K | Buy |
9,277
+79
| +0.9% | +$7.03K | 0.3% | 93 |
|
|
2015
Q2 | $811K | Sell |
9,198
-223
| -2% | -$20.5K | 0.28% | 105 |
|
|
2015
Q1 | $832K | Hold |
9,421
| – | – | 0.27% | 110 |
|
|
2014
Q4 | $782K | Hold |
9,421
| – | – | 0.26% | 118 |
|
|
2014
Q3 | $795K | Hold |
9,421
| – | – | 0.27% | 115 |
|
|
2014
Q2 | $764K | Hold |
9,421
| – | – | 0.25% | 122 |
|
|
2014
Q1 | $718K | Hold |
9,421
| – | – | 0.25% | 114 |
|
|
2013
Q4 | $679K | Hold |
9,421
| – | – | 0.24% | 120 |
|
|
2013
Q3 | $648K | Hold |
9,421
| – | – | 0.26% | 116 |
|
|
2013
Q2 | $597K | Buy |
+9,421
| New | +$613K | 0.23% | 127 |
|
Other funds holding NVS
Duncker Streett & Co's NVS Position: Q2 2026 in Review
Duncker Streett & Co held its Novartis (NVS) position steady in Q2 2026 at 552 shares worth $86.5K. The position accounts for 0.01% of the portfolio, ranked #290.
Duncker Streett & Co first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $919K in Q3 2018. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Duncker Streett & Co held 552 shares of Novartis worth $86.5K as of Q2 2026.
- Duncker Streett & Co left its Novartis share count unchanged in Q2 2026.
- Novartis made up 0.01% of Duncker Streett & Co's portfolio in Q2 2026, its #290 holding.
- Duncker Streett & Co first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- Duncker Streett & Co's Novartis position peaked at $919K in Q3 2018.
- 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Duncker Streett & Co's 13F filing for Q2 2026, filed 28 Jul 2026.